Nextcure Stock Price on December 9, 2024
| NXTC Stock | USD 0.89 0.08 8.25% |
Below is the normalized historical share price chart for NextCure extending back to May 09, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NextCure stands at 0.89, as last reported on the 24th of December, with the highest price reaching 0.99 and the lowest price hitting 0.89 during the day.
If you're considering investing in NextCure Stock, it is important to understand the factors that can impact its price. NextCure has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12% return per unit of risk over the last 3 months. NextCure exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NextCure's Mean Deviation of 2.82, risk adjusted performance of (0.09), and Standard Deviation of 3.96 to check out the risk estimate we provide.
At present, NextCure's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, NextCure's Price To Book Ratio is projected to increase based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 0.29, whereas Price To Sales Ratio is forecasted to decline to 14.65. NextCure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of May 2019 | 200 Day MA 1.4941 | 50 Day MA 1.254 | Beta 0.791 |
NextCure |
Sharpe Ratio = -0.1161
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NXTC |
Estimated Market Risk
| 4.02 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NextCure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NextCure by adding NextCure to a well-diversified portfolio.
Price Book 0.3486 | Enterprise Value Ebitda 0.5081 | Price Sales 9.5227 | Shares Float 18.6 M | Wall Street Target Price 3.3333 |
Related Headline
Spero Therapeutics Headline on 9th of December 2024
BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.
NextCure Valuation on December 9, 2024
It is possible to determine the worth of NextCure on a given historical date. On December 9, 2024 NextCure was worth 1.18 at the beginning of the trading date compared to the closed value of 1.16. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NextCure stock. Still, in general, we apply an absolute valuation method to find NextCure's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NextCure where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NextCure's related companies.
| Open | High | Low | Close | Volume | |
| 1.09 | 1.15 | 1.00 | 1.14 | 2,341,580 | |
12/09/2024 | 1.18 | 1.20 | 1.08 | 1.16 | 78,500 |
| 1.21 | 1.21 | 1.07 | 1.13 | 83,570 |
| Backtest NextCure | | | NextCure History | | | NextCure Valuation | Previous | Next |
NextCure Trading Date Momentum on December 9, 2024
| On December 10 2024 NextCure was traded for 1.13 at the closing time. The top price for the day was 1.21 and the lowest listed price was 1.07 . The trading volume for the day was 83.6 K. The trading history from December 10, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.59% . The trading delta at closing time against the current closing price is 18.97% . |
NextCure Fundamentals Correlations and Trends
By evaluating NextCure's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NextCure's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NextCure financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NextCure Stock history
NextCure investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NextCure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NextCure will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NextCure stock prices may prove useful in developing a viable investing in NextCure
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 27.8 M | 23 M | |
| Net Loss | -67.3 M | -70.6 M |
NextCure Quarterly Net Working Capital |
|
NextCure Stock Technical Analysis
NextCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NextCure Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
NextCure cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NextCure December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how NextCure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NextCure shares will generate the highest return on investment. By undertsting and applying NextCure stock market strength indicators, traders can identify NextCure entry and exit signals to maximize returns
NextCure Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NextCure's price direction in advance. Along with the technical and fundamental analysis of NextCure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NextCure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.42) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |